Articles On Virtus Health (ASX:VRT)

Wesfarmers Ltd (ASX: WES) shares had a good month over July. No, a phenomenal month. There is no other word for it. The ASX 200 blue-chip stock and industrial and retailing conglomerate began July at $65.18 a share. But by the time trading...

The Wesfarmers Ltd (ASX: WES) share price is up 0.3% after the company revealed it had appointed a new director with significant healthcare and services experience. This movement comes with the S&P/ASX 200 Index (ASX: XJO) currently dow...

ASX healthcare shares have underperformed the broader market since the pandemic-induced market lows in March 2020. Over the last three years, the S&P/ASX 200 Healthcare index has returned just 5.5% per year compared to the S&P/ASX 2...

Domestic credit funds and overseas banks have tipped money into BGH Capital’s $495 million debt package to help pay for IVF provider Virtus Health.

Virtus Health delisted on August 4, but UBS is still trying to sell the debt it underwrote for the take-private.

The takeover action evident at the top end of town is trickling down to the small and mid cap sectors, as mainly foreign marauders avail of the undervalued morsels on offer. In theory, the end of cheap money should have crimped takeover act...

Gold aspirant Cavalier Resources announces its new substantial shareholders following IPO Gold stocks in demand as investors seek the traditional inflationary hedge Hard hit health and e-commerce stocks continue to lose substantial shareho...

Highlights: The Australian stock market ended the week on a positive note at 6,578.70 points. Most of the sectors closed in the green territory today.   The Australian stock market ended the week on a positive note. On Friday, the...

Nordic Nickel announces its new substantial shareholders following its June 2 debut Sigma Healthcare defies ASX health stocks to keep rising and attract new substantial shareholders Hard-hit e-commerce and health stocks among those to lose...

The Virtus Health Ltd (ASX: VRT) share price is lifting on Friday despite the broader market’s suffering. Right now, the S&P/ASX 200 Index (ASX: XJO) has slumped 0.75% while the All Ordinaries Index (ASX: XAO) has dipped 0.93%. Meanw...

ShareCafeEvening Report: 3 June, 2022 by Lauren Evans   The Australian sharemarket closed higher for a third straight week after advancing on Friday’s session, which offset yesterday’s fall. At the closing bell, the ASX 200 was 0.9 per cent...

ASX healthcare index finishes another week in the red Enterprise imaging stocks tipped to be a first recovery The goliath battle for fertility company Virtus comes to an end Healthcare and life sciences expert Scott Power – a senior analy...

ShareCafeLunch Report: 3 June, 2022 by Melissa Darmawan   The Australian sharemarket jumped at the open, recovering all of yesterday’s losses in a broad-based rally. If the momentum continues, the ASX 200 is on track to extend its winning s...

BGH increases holdings in Virtus Health as battle for fertility company escalates Out of favour health stocks attract attention of big money managers ASX gold stocks see changes in substantial holdings as price of precious metal falls in m...

ShareCafeEvening Report: 30 May, 2022 by Lauren Evans   The ASX 200 rose for a second successive day led by technology, materials and bank shares. At the closing bell, the index was 1.5 per cent or 104 points higher at 7,287, its best perfo...

ShareCafeLunch Report: 30 May, 2022 by Melissa Darmawan   Australian shares jumped to a three week high after a strong lead from Wall St. Every sector is rallying, bar utilities after news from AGL. The optimism is led by technology shares,...

The S&P/ASX 200 (ASX: XJO) delivered a strong finish to the week, gaining 1.1% on the back of a strong global lead. The primary driver was a weakening of the rhetoric from US Federal Reserve Chair, Jerome Powell in relation to the cours...

Virtus Health and its bankers are scrambling to chase down the company’s shareholders and get them to accept an $8.15 a share bid from BGH Capital. 

Highlights ASX 200 closed higher today, crossing its 20-day moving average. The benchmark index closed up, gaining 76.80 points or 1.08% to 7,182.70. Energy sector was the top performer followed by consumer discretionary. Closing...

ShareCafeEvening Report: 27 May, 2022 by Lauren Evans   Australian shares had their best day this week buoyed by resources and travel stocks while news in the M&A space also got some attention. Wall Street provided a solid lead with its...

Dark clouds continue to hover over ASX health stocks Health imaging company Volpara’s FY22 results in line with expectations Fight for fertility company Virtus enters another round Healthcare and life sciences expert Scott Power – a senio...

It’s shaping up to be a rather pleasant end to the week for ASX shares and the S&P/ASX 200 Index (ASX: XJO). So far this Friday, the ASX 200 has put on a healthy 0.82% and is back over 7,150 points. But the same can’t be said for the C...

ShareCafeLunch Report: 27 May, 2022 by Melissa Darmawan   Travel stocks are stronger for a second straight day as Australian shares rally on the back of a strong lead from Wall St. A batch of upbeat earnings reports with several retailers u...

BGH Capital is now in the box seat to acquire Australia’s biggest IVF group after Virtus Health switches support following the recommended suitor CapVest going silent.

Highlights ASX 200 didn’t sustain morning cheers, closed 0.69% lower on weak Chinese growth cues. Top performer was information technology sector, up 1.09%, with Appen (ASX:APX) as top gainer. Appen, Virtus Health, Westpac, were newsm...

Highlights The Australian share market opened higher on Thursday following positive handover from Wall Street. However, the benchmark index soon succumbed to profit booking in mining stocks and slipped into the red. Six of 11 sectors...

ASX lower as tech stocks fall on Snap warning. BGH Capital matches CapVest's Virtus offer, Mercer set to buy BT Super, Crown targets June takeover and The Lottery Corp debuts.

While Mike Cannon-Brookes and AGL Energy hog the limelight in large caps, in small caps land the epic battle for IVF provider Virtus Health is set to come to a head. 

UK’s CapVest Partners has begun passing around the hat to collect just under $500 million for its $8.17 a share bid to buy listed IVF business Virtus Health. 

Billionaire prospector Mark Creasy increase his Galileo Mining substantial holdings Metgasco’s new UK substantial holder is attracting interest from investors Major investment firms look to increase holdings in gold miners Trading Places...

As PE battles for Virtus Health, smaller rival Genea has a $202 million takeover of its own.

The S&P/ASX 200 (ASX: XJO) finished the week on a high note, gaining 1.9% on the back of an incredible surge in the technology sector. The mid-session turnaround in the Nasdaq pushed the ASX technology sector to a 6.9% gain after US-lis...

M&A activity remains strong in health sector despite falling markets Polynovo shares defy bearish market surging ~28% in past five days Audeara reports it is continuing to see a rebound to more normal trading conditions Healthcare and...

The Virtus Health Ltd (ASX: VRT) share price is firmly nested at its previous closing price today. Typically, that would be a non-event not worth reporting on. However, today it is striking considering what the fertility treatment company...

The ASX healthcare sector rebounds on back of $20 billion Ramsay Healthcare takeover bid Volpara founder and CEO steps into new role as female CEO takes the reins Medlab Clinical shares soar after UK trade deal for probiotic for patients...

There’s plenty of drama still to play out in the takeover battle for IVF business Virtus Health, including some allegations of misleading conduct.

It was another volatile day for the S&P/ASX 200 (ASX: XJO), with the market trading significantly higher before reversing gains to finish up just 0.1%. The ASX 200 and individual sectors continue to diverge on a daily basis as the press...

London-based buyout firm CapVest has its head clearly back in front in the race for Australia’s Virtus Health. 

S&P/ASX 200 healthcare index modestly up 0.16% for week Gut health company Microba falls on IPO Rhythm Biosciences bowel cancer blood screening test milestone Have a habit of forgetting where you put your keys or mobile phone? You ma...

The threat of quantitative tightening extended to Australia on Thursday, with the S&P/ASX 200 (ASX: XJO) being dragged down another 0.6%, almost solely due to the technology sector. Just three sectors finished higher during the session,...

The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow...

The share market fell for a second day as global financial markets continued to adjust to a fast-changing rates outlook. The S&P/ASX 200 dropped 47 points or 0.63 per cent to its lowest close in a week and a half. Rate-sensitive g...

Tech stocks led declines for a second day as investors rotated out of sectors most at risk from higher rates into defensive value plays. The S&P/ASX 200 dropped 34 points or 0.46 per cent by mid-session. Technology, banking and mi...

The Virtus Health Ltd (ASX: VRT) share price is frozen today amid a bidding war for the company. The company’s shares were trading at $8.15 before grinding to a halt. In yesterday’s trade, the Virtus Health share price climbed 1.37%. Vir...

CapVest is set to make its fourth bid for Virtus Health. 

Aussie shares fell to their lowest in a week as a Covid-fuelled slowdown in major trading partner China compounded weak leads from the US. The S&P/ASX 200 fell 1.2 per cent before more than halving its fall to 38 points or 0.5 per ce...

The share price of fertility treatment provider Virtus Health Ltd (ASX: VRT) closed higher today on the back of its seventh takeover offer. This time, BGH Capital is back in the hot seat with an $8 per share off-market takeover bid posed t...

The share market suffered its biggest setback in almost a month as the prospect of tighter monetary policy on both sides of the Pacific brought out sellers. The S&P/ASX 200 slid 50 points or 0.66 per cent by mid-session. Today’s retr...

With the board of fertility specialist Virtus Health (ASX: VRT) unanimously recommending shareholders vote in favour of a $706 million takeover from UK private equity firm CapVest at a meeting in June, the company that started the bidding w...

06 Apr 2022 - A snapshot of the stocks on the move featuring Virtus Health (ASX:VRT), Ventia Services Group (ASX:VNT) & Crown Resorts (ASX:CWN).